17308011000001101: Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Nabumetone\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Nabumetone\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing prostaglandin-endoperoxide synthase isoform 2 inhibitor (product)\Product containing nabumetone\Nabumetone\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing prostaglandin-endoperoxide synthase isoform 2 inhibitor (product)\Product containing nabumetone\Nabumetone\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing prostaglandin-endoperoxide synthase isoform 2 inhibitor (product)\Product containing nabumetone\Product containing nabumetone in oral dose form (medicinal product form)\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing nabumetone\Nabumetone\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing nabumetone\Nabumetone\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with ether structure (product)\Product containing nabumetone\Product containing nabumetone in oral dose form (medicinal product form)\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ketone\Product containing nabumetone\Nabumetone\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ketone\Product containing nabumetone\Nabumetone\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ketone\Product containing nabumetone\Product containing nabumetone in oral dose form (medicinal product form)\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing nabumetone\Nabumetone\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing nabumetone\Nabumetone\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing nabumetone\Product containing nabumetone in oral dose form (medicinal product form)\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing nabumetone in oral dose form (medicinal product form)\Product containing only nabumetone in oral dose form (medicinal product form)\Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet\Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Jun 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

60042301000001113 Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

60042401000001117 Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Is a	Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Has active ingredient	Nabumetone	false	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Has specific active ingredient	Nabumetone	true	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd) 56 tablet	Has AMP	True	Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
60042301000001113	Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
60042401000001117	Nabumetone 500mg tablets (Beechmere Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module